Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Cancer Res Treat
; 54(4): 1240-1255, 2022 Oct.
Article
em En
| MEDLINE
| ID: mdl-35038826
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fibromatose Agressiva
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article